Spin-off or demerger being considered by Aurobindo
Aurobindo Pharma is considering demerging its API and formulation businesses to unlock value and better serve clients.
Archives for May 10, 2011
Direct San Diego to London flight boon for drug sector says Biotec
A new direct flight between London Heathrow and San Diego from 1st June 2011 will benefit the international biotech sector according to UK-based Biotec Services International.
WuXi posts strong Q1 results on lab services gains
Shanghai-based contract research organisation (CRO) WuXi PharmaTech has announced strong financial results for the first quarter, 2011.
Ph II trial failure rates rise, calling for quality focus not wishful thinking
Pharma industry wishful thinking and the fact too many developers have been chasing too few targets are behind an increase in Phase II failures in recent years according to a new study.
update
Quintiles resurrects refinancing plan
US contract research organisation (CRO) Quintiles has resurrected plans to refinance in a bid to clear debts in a more healthy credit market.
Rival’s problems create market opportunity, claims Medidata
Medidata claims it is winning new business as operational challenges at a key competitor make clients open to alternatives.
Jubilant plans expansions, new plants to build in Q4 growth
Jubilant Life Sciences is to build an intermediate plant and expand production to continue double-digit growth seen in the fourth quarter.